103 Results (Page 1 of 9)
Italy Markets Research Reports
Italy Diabetes Devices Market Analysis
The Italy Diabetes Devices Market is expected to witness growth from $546 Mn in 2022 to $916 Mn in 2030 with a CAGR of 6.70% for the forecasted year 2022-2030. In Italy, the number of cases of diabetes has been gradually rising in recent years. The market for diabetes devices and associated goods will increase as a result of this trend. The market is segmented by type and by the end user. Some key players in this market include Ormesa S.R.L, Angelantoni Life Science, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Italy Cardiac Surgery Instruments Market Analysis
The Italy Cardiac Surgery Instruments Market is expected to witness growth from $50 Mn in 2022 to $80 Mn in 2030 with a CAGR of 6.10% for the forecasted year 2022-2030. Ambulatory surgical facilities are becoming more popular in Italy due to their benefits, which include lower expenses, shorter hospital stays, and quicker recovery times. The need for specialized cardiac surgery instruments has grown because ambulatory surgical centres need them to perform procedures, which leads to a growth of the market for these instruments in the Italian healthcare sector. The market is segmented by type, application and by end user. Some key players in this market include Progetti Srl, Esaote SpA, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Italy Cardiovascular Diseases Therapeutics Market Analysis
Italy cardiovascular disease therapeutics market is projected to grow from $3.9 Bn in 2022 to $6.5 Bn in 2030 with a CAGR of 6.72% for the year 2022-2030. The rising elderly population and hence the growing incidences of cardiovascular diseases in Italy are responsible for the growth of the market. The Italy cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Meda Pharma, Truffini & Reggè Farmaceutici, and Bristol-Myers Squibb are the major players in the Italy cardiovascular disease therapeutics market.
Italy Anti Aging Therapeutics Market Analysis
Italy anti-aging therapeutics market is expected to witness growth from $14 Mn in 2022 to $48 Mn in 2030 with a CAGR of 16.03% for the year 2022-2030. The rising awareness about age-related disorders among the Italian population and growing investments in anti-aging treatments in Italy by major biotechnology companies are driving the growth of the market. The Italy anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Recipharm, Italfarmaco, and Cambrian Biopharma are among the leading players in the market.
Italy Artificial Intelligence (AI) in Healthcare Market Analysis
Italy's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.17 Bn in 2022 to $3.19 Bn by 2030, registering a CAGR of 44.72% during the forecast period of 2022-30. The market will be driven by increasing demand for innovative and effective healthcare services, the rising availability of healthcare data, and the implementation of electronic health records (EHRs). The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google Health, TeiaCare & surgiQ.
Italy Healthcare Insurance Market Analysis
The Italy healthcare insurance market is projected to grow from $48.63 Bn in 2022 to $84.18 Bn by 2030, registering a CAGR of 7.1% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing chronic disease prevalence, regulatory changes, private insurance market growth and technological advances. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Generali, Intesa Sanpaolo Vita, Poste Vita, Unipol and Cattolica.
Italy Healthcare Claims Management Market Analysis
The Italy healthcare claims management market is projected to grow from $640.8 Mn in 2022 to $3335.32 Mn by 2030, registering a CAGR of 22.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing healthcare spending, increasing health insurance coverage, technological advancements, regulatory compliance and an ageing population. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Dedalus, UnipolSai, DWF Group, Cognizant and Accenture.
Italy Healthcare Financial Analytics Market Analysis
The Italy Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Italy’s Healthcare Financial Analytics market will grow as the demand for data-driven decision-making is rising, and financial analytics. The key market players are IBM Watson Health, Zucchetti Group, Optum Italia, Oracle Italia, SAS Institute Italiaand others.
Italy ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Italy's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $709 Mn in 2022 to $1,219 Mn in 2030 with a CAGR of 7% for the year 2022-30. Increasing prevalence and the rise in demand for treatment options for ADHD in Italy are likely the growth drivers for the market expansion. The Italy ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Farmaka, Medac Pharma, and Alcobra are the key players in the market.
Italy Dental Care Market Analysis
The Italy dental care market size was valued at $0.6 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.25% from 2022 to 2030 and will reach $1.36 Bn in 2030. This growth is expected to be driven by factors such as the increasing prevalence of dental problems, the growing demand for cosmetic dentistry procedures, and the adoption of advanced dental technologies. The market is segmented by Product Type, By Age Group, By Sales Channel, and End User. Italy’s major dental care players are 3M, A-Dec Inc., Biolase Inc., Carestream Health Inc., and Others.
Italy Oncology Clinical Trials Market Analysis
Italy's oncology clinical trials market is projected to grow from $303.6 Mn in 2022 to $448.6 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer in Italy & well-established research infrastructure and regulatory environment. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & MolMed S.p.A.
Italy Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Italy Liver Disease Therapeutics market will reach a value of $831 Mn from $554 Mn in 2022, growing at a CAGR of 5.2% during 2022-2030. Liver Disease Therapeutics in Italy is dominated by a few domestic pharmaceutical companies such as Esaote, Chiesi Group, and Dompé. The Liver Disease Therapeutics market in Italy is segmented into different types of disease and different therapy types. Some of the major factors affecting the Italy Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Italy Oral Care Market Analysis
The Italy Oral Care market was valued at $846 Mn in 2022 and is estimated to expand at a CAGR of 5.7% from 2022 to 2030 and will reach $1317 Mn in 2030. One of the main reasons propelling the growth of this market is introduction of Increasing Demand for Natural and Organic Products, aging population. The market is segmented by type, drug and distribution channel. Some key players in this market are 3M, A-Dec Inc., Biolase Inc., Carestream Health Inc., Dentsply Sirona, and Envista Holdings Corporation among others.
Italy Multiple Myeloma Therapeutics Market Analysis
The Italy Multiple Myeloma Therapeutics Market was valued at $200 Mn in 2022 and is estimated to expand at a CAGR of 4% from 2022 to 2030 and will reach $274 Mn in 2030. One of the main reasons propelling the growth of this Market is Advancements in technology, aging population. The Market is segmented by type, drug and distribution channel. Some key players in this Market are Menarini Group, Sigma-Tau Group, Chiesi Pharmaceutics and others.
Italy Diabetes Drugs Market Analysis
The Italy diabetes drugs market size was valued at $1.48 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030 and will reach $2.29 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Italy diabetes drug market will grow because, the Italian government has implemented a range of initiatives aimed at improving diabetes management and reducing the burden of the disease on the healthcare system. The key market players are Chiesi Farmaceutici (ITA), Menarini Group (ITA), Boehringer Ingelheim, Sanofi, Boehringer Ingelheim and others.
Italy Robotic Surgery Services Market Analysis
Italy's robotic surgery service market size was valued at $103 Mn in 2022 and is estimated to expand at a CAGR of 18.8% from 2022-30 and will reach $409 Mn in 2030. The robotic surgery service market will grow due to the rising need for top-notch medical services, particularly cutting-edge surgical operations, as Italy's economy and population continue to expand and people live in greater prosperity. The market is segmented by product and service type, application type, and end user. Some of the major players are SIAS srl (ITA), MeDiRobotics (ITA), Endoassist (ITA), Quirumed (ITA), Micro-Innovation (ITA), and others.
Italy Connected Healthcare Market Analysis
The Italy-connected healthcare market is projected to grow from $1.59 Bn in 2022 to $11.41 Bn by 2030, registering a CAGR of 27.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rising geriatric population, chronic disease prevalence, technological advancements and government support. The market is segmented by type, function and by application. Some of the major players include Reply, D0Eye, Plusimple, Philips Healthcare, IBM and Siemens Healthineers.
Italy Artificial Intelligence (AI) in Medical Imaging Market Analysis
Italy artificial intelligence (AI) in medical Imaging market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 34.9% from 2022 to 2030 and will reach $395 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the Italy Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market are Canon Medical Systems, Barco, Medtronic, GE Healthcare, Siemens Healthineers, Hologic, Koninklijke Philips, Fujifilm, Brainomix, Quibim, and others.
Italy Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Italy Primary Hyperoxaluria (PH) Therapeutics Market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 4.3 % from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is advancement in technology, aging population. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market are Dicerna Pharmaceuticals, OxThera, Allena Pharmaceuticals, and Recordati Rare Diseases, among others.
Italy Neurology Clinical Trials Market Analysis
The Italy Neurology Clinical Trials market is projected to grow from $125.5 Mn in 2022 to $185.5 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022 - 2030. The market will be driven by the rising demand for novel therapies for neurological disorders and the supportive regulatory climate in Italy. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca, Chiesi Farmaceutici & Menarini.
Italy 3D Printing Medical Devices Market Analysis
The Italy 3D Printing Medical Devices market size was valued at $71 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.8% from 2022 to 2030 and will reach $230 Mn in 2030. The market is segmented by component, application, technology, and end user. The Italy 3D Printing Medical Devices market will grow The 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include 3D-Side, EGO3D, Mecuris Italia, MT Ortho, REJOINT, Storm Line, WASP MED, and others.
Italy Alzheimer’s Disease Drugs Market Analysis
Italy's Alzheimer’s Disease Drugs market was valued at $370 Mn in 2022 and is estimated to expand at a CAGR of 7.92% from 2022-30 and will reach $681 Mn in 2030. One of the main reasons propelling the growth of this market is the rising prevalence and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Bayer, Boehringer Ingelheim, Fresenius Medical Care AG & Co. KGaA, Siemens Healthineers, Sanofi, Roche, Novartis, GlaxoSmithKline, Eisai Co., Eli Lilly and Company, H. Lundbeck A/S and Johnson and Johnson among others.
Italy Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The Italy COPD Therapeutics Market was valued at $438 Mn in 2022 and is estimated to expand at a CAGR of 6.6% from 2022 to 2030 and will reach $730 Mn in 2030. One of the main reasons propelling the growth of this market is the increasing prevalence rate, Aging population. The market is segmented by Drug class and By distribution channel. Some key players in this market are Menarini Group, Chiesi Pharma, Almirall, Molteni Pharmaceutics, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Italy Limited, and others.
Italy Teleradiology Market Analysis
The Italy Teleradiology market size was valued at $57 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 11.2% from 2022 to 2030 and will reach $ 133 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Italy teleradiology market will grow due to advancements in technology, such as electronic medical records (EMRs) and picture archiving and communication systems (PACS), have made it easier to transmit and store medical images securely. The key market players are Telemedicina Italiana S.r.l., LaBS - Laboratorio di Bioingegneria e di Informatica Sanitaria, MEDICAIM S.r.l., Telerradiologia Italia S.r.l., Telerad Italia S.r.l., and others.
Italy Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Italy infectious disease therapeutics market will reach a value of $3.89 Bn from $2.88 Bn in 2022, growing at a CAGR of 3.9% during 2022-2030. Infectious Disease Therapeutics in Italy is dominated by a few domestic pharmaceutical companies such as Menarini, Dompé and IRBM. The infectious disease therapeutics market in Italy is segmented into different therapeutic areas and different treatment types. The major factors affecting the Italy infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of Italy.